Literature DB >> 35486127

Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam.

Chao Ge1, Huidong Wang1,2, Kunzhi Chen1, Wuji Sun1, Huicheng Li3, Yinghua Shi4.   

Abstract

PURPOSE: The purpose of this study is to investigate the effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung stereotactic body radiation therapy (SBRT) using volumetric modulated arc therapy (VMAT) with 6 MV flattening-filter-free (FFF) beam.
METHODS: Twenty patients with early stage non-small cell lung cancer were included. For each patient, high-complexity (HC) and low-complexity (LC) three-partial-arc VMAT plans were optimized by adjusting the normal tissue objectives and the maximum monitoring units (MUs) for a Varian TrueBeam linear accelerator (Varian Medical Systems, Palo Alto, CA, USA) using 6 MV FFF beam. The effect of plan complexity was comprehensively evaluated in three aspects: (1) The dosimetric parameters, including CI, D2cm, R50, and dose-volume parameters of organs at risk were compared. (2) The delivery accuracy was assessed by pretreatment quality assurance for two groups of plans. (3) The motion-induced dose deviation was evaluated based on point dose measurements near the tumor center by using a programmable phantom. The standard deviation (SD) and maximum dose difference of five measurements were used to quantify the interplay effect.
RESULTS: The dosimetry of HC and LC plans were similar except the CI (1.003 ± 0.032 and 1.026 ± 0.043, p = 0.030) and Dmax to the spinal cord (10.6 ± 3.2 and 9.9 ± 3.0, p = 0.012). The gamma passing rates were significantly higher in LC plans for all arcs (p < 0.001). The SDs of HC and LC plans ranged from 0.5-16.6% and 0.03-2.9%, respectively, under the conditions of one-field, two-field, and three-field delivery for each plan with 0.5, 1, 2, and 3 cm motion amplitudes. The maximum dose differences of HC and LC plans were 34.5% and 9.1%, respectively.
CONCLUSION: For lung VMAT SBRT, LC plans have a higher delivery accuracy and a lower motion-induced dose deviation with similar dosimetry compared with HC plans.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Dosimetric distribution; Dynamic measurement; Gamma passing rate; Intrafration motion; Lung neoplasms

Mesh:

Year:  2022        PMID: 35486127     DOI: 10.1007/s00066-022-01940-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   4.033


  35 in total

1.  Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Authors:  Gregory M Videtic; Rebecca Paulus; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Robert D Timmerman; Ritsuko R Komaki; James J Urbanic; Kevin L Stephans; Sue S Yom; Clifford G Robinson; Chandra P Belani; Puneeth Iyengar; Munther I Ajlouni; Darindra D Gopaul; Jorge B Gomez Suescun; Ronald C McGarry; Hak Choy; Jeffrey D Bradley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-01       Impact factor: 7.038

2.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Authors:  Achilles J Fakiris; Ronald C McGarry; Constantin T Yiannoutsos; Lech Papiez; Mark Williams; Mark A Henderson; Robert Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-27       Impact factor: 7.038

3.  Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.

Authors:  Jun Li; James Galvin; Amy Harrison; Robert Timmerman; Yan Yu; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-24       Impact factor: 7.038

Review 4.  What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans.

Authors:  Victor Hernandez; Christian Rønn Hansen; Lamberto Widesott; Anna Bäck; Richard Canters; Marco Fusella; Julia Götstedt; Diego Jurado-Bruggeman; Nobutaka Mukumoto; Laura Patricia Kaplan; Irena Koniarová; Tomasz Piotrowski; Lorenzo Placidi; Ana Vaniqui; Nuria Jornet
Journal:  Radiother Oncol       Date:  2020-09-25       Impact factor: 6.280

Review 5.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

6.  Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Authors:  David Ball; G Tao Mai; Shalini Vinod; Scott Babington; Jeremy Ruben; Tomas Kron; Brent Chesson; Alan Herschtal; Marijana Vanevski; Angela Rezo; Christine Elder; Marketa Skala; Andrew Wirth; Greg Wheeler; Adeline Lim; Mark Shaw; Penelope Schofield; Louis Irving; Benjamin Solomon
Journal:  Lancet Oncol       Date:  2019-02-12       Impact factor: 41.316

7.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

8.  Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy.

Authors:  Chin Loon Ong; Max Dahele; Ben J Slotman; Wilko F A R Verbakel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-15       Impact factor: 7.038

9.  Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.

Authors:  Wilko F A R Verbakel; Jaap van den Berg; Ben J Slotman; Peter Sminia
Journal:  Acta Oncol       Date:  2012-11-06       Impact factor: 4.089

10.  Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.

Authors:  Geoffrey G Zhang; Lichung Ku; Thomas J Dilling; Craig W Stevens; Ray R Zhang; Weiqi Li; Vladimir Feygelman
Journal:  Radiat Oncol       Date:  2011-11-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.